Umbralisib Inhibits PI3K{delta} with Less Toxicity Than Previous Inhibitors [Research Watch]

Umbralisib is well tolerated and has activity against relapsed or refractory hematologic cancers.

from Cancer via ola Kala on Inoreader http://ift.tt/2oECvjj
via IFTTT